![Michael Wootton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Wootton
Chief Executive Officer at NF2 Therapeutics, Inc.
Profile
Michael Wootton is the President and Director of NFlection Therapeutics, Inc. which he founded in 2014.
Mr. Wootton is also the founder of NF2 Therapeutics, Inc.
Michael Wootton active positions
Companies | Position | Start |
---|---|---|
NF2 Therapeutics, Inc.
![]() NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Chief Executive Officer | - |
Former positions of Michael Wootton
Companies | Position | End |
---|---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Founder | - |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Health Technology |
NF2 Therapeutics, Inc.
![]() NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Michael Wootton